This study is in progress, not accepting new patients
Safety Study of AADC Gene Therapy (VY-AADC01) for Parkinson's Disease
a study on Parkinson's Disease
Parkinson's DiseasePDAromatic Amino Acid DecarboxylaseAADCAAV2-AADCAAV2Viral VectorGene TherapyGene TransferMRIPETVY-AADC01Parkinson DiseaseDopa DecarboxylaseVY-AADC01 Dose 1VY-AADC01 Dose 2VY-AADC01 Dose 3
Lead Scientist at UCSF
- Paul Larson
Dr. Paul Larson is Professor and Vice Chair of Neurological Surgery at the University of California San Francisco, Chief of Neurosurgery at the San Francisco VA Medical Center and Surgical Director of the Parkinson’s Disease Research, Education and Clinical Center. He specializes in functional neurosurgery, specifically deep brain stimulation for movement disorders and MR-guided procedures.